Palisade Bio (STU:7NS0) Total Liabilities : €2.38 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Total Liabilities?

Palisade Bio's Total Liabilities for the quarter that ended in Mar. 2024 was €2.38 Mil.

Palisade Bio's quarterly Total Liabilities declined from Sep. 2023 (€2.80 Mil) to Dec. 2023 (€2.51 Mil) and declined from Dec. 2023 (€2.51 Mil) to Mar. 2024 (€2.38 Mil).

Palisade Bio's annual Total Liabilities declined from Dec. 2021 (€4.56 Mil) to Dec. 2022 (€3.10 Mil) and declined from Dec. 2022 (€3.10 Mil) to Dec. 2023 (€2.51 Mil).

Palisade Bio Total Liabilities Historical Data

The historical data trend for Palisade Bio's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Total Liabilities Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Liabilities

16.13

4.56

3.10

2.51

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial											1.42	2.30	2.80	2.51	2.38

Palisade Bio Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Palisade Bio's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.371	+	(0.083	+	0.058
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.51

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	12.886	-	10.374
	=	2.51

Palisade Bio's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.27	+	(0.053	+	0.058
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.38

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	11.64	-	9.259
	=	2.38

Palisade Bio Total Liabilities Related Terms

Thank you for viewing the detailed overview of Palisade Bio's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio (STU:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

PALI:USA 7NS:Germany

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines